Literature DB >> 15266112

Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children.

Stephen Meddows-Taylor1, Maria A Papathanasopoulos, Louise Kuhn, Tammy M Meyers, Caroline T Tiemessen.   

Abstract

Although human immunodeficiency virus type 1 (HIV-1) specific CD4 T-helper cells are vital in mediating antiviral defence, little is known concerning the influence of HIV-1 antigenic variation on CD4 T-cell responses. In this study, the amino acid sequences of 5 synthetic HIV-1 envelope peptides used for in vitro stimulation (T2, P18 MN, P18 IIIB, T1 and TH4.1) were compared to the corresponding amino acid sequences of the gp 160 region of viruses isolated from HIV-1 infected children to determine whether variation in the envelope region of HIV-1 was associated with the ability to detect Env-specific T-helper cell responses. Although the T2 region appeared to offer some evidence as to the role antigenic variation may have played in class II-restricted CD4 T-cell responses between those children who showed a detectable Env-stimulated T-helper cell response and those who did not, the other regions studied showed no evidence of being more conserved among those children who showed detectable responses. The combined amino acid variation across the specific peptide regions studied was not associated with peripheral levels of HIV-1, nor did the degree of amino acid variation dictate the clinical category into which the children had been classified, although there was a tendency towards HIV-1 isolates from the younger children showing a greater degree of amino acid variation than isolates from the older children. These results suggest that HIV-1 specific CD4 responses may be somewhat tolerant of viral variation, although further studies are required to fully elucidate the effect of antigenic variation on immune recognition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15266112      PMCID: PMC2364720          DOI: 10.1023/b:viru.0000025788.85010.bd

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  34 in total

1.  Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.

Authors:  P Klenerman; S Rowland-Jones; S McAdam; J Edwards; S Daenke; D Lalloo; B Köppe; W Rosenberg; D Boyd; A Edwards
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

2.  T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction.

Authors:  P M Hale; K B Cease; R A Houghten; C Ouyang; S Putney; K Javaherian; H Margalit; J L Cornette; J L Spouge; C DeLisi
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

3.  Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.

Authors:  J A Berzofsky; C D Pendleton; M Clerici; J Ahlers; D R Lucey; S D Putney; G M Shearer
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

4.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 5.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

6.  Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

Authors:  M Clerici; J V Giorgi; C C Chou; V K Gudeman; J A Zack; P Gupta; H N Ho; P G Nishanian; J A Berzofsky; G M Shearer
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

7.  HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.

Authors:  M Clerici; J M Levin; H A Kessler; A Harris; J A Berzofsky; A L Landay; G M Shearer
Journal:  JAMA       Date:  1994-01-05       Impact factor: 56.272

8.  Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected].

Authors:  M Clerici; J A Berzofsky; G M Shearer; C O Tacket
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

9.  Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D C Bernstein; D L Mann; G M Shearer; J A Berzofsky
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

10.  Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.

Authors:  H Groux; G Torpier; D Monté; Y Mouton; A Capron; J C Ameisen
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  1 in total

1.  Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs.

Authors:  Sinu Paul; Helen Piontkivska
Journal:  BMC Microbiol       Date:  2010-08-09       Impact factor: 3.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.